Coronary Angiography Devices Market By Product (Angiography Systems, Angiography Catheters, Vascular Closure Devices (VCDS), Angiography Balloons, Angiography Guidewires and Others), By Technology (X-Ray Angiography, CT Angiography, MR Angiography and Others), By Application (Diagnostics and Therapeutics) By End User (Hospitals, Diagnostic Centers and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 owing to the Increase in Prevalence of Cardiovascular Diseases and the Increase observed in the numbers of Coronary Angiography Procedures.
Global Coronary Angiography Devices Market was valued at USD 11.72 billion in 2021, growing at a CAGR of 6.18% during the forecast period from 2022 to 2027, to reach USD 16.80 billion by 2027. The demand for Coronary Angiography Devices is primarily witnessing growth on account of the growing prevalence of cardiovascular diseases, rising numbers of coronary angiography procedures, technological advancements in coronary angiography devices and increasing product approvals for advanced angiography techniques.
The rising prevalence of patients suffering from cardiovascular disease is one of the leading cause of death globally, taking an estimated 17.9 million lives every year. According to the World Health Organization (WHO), more than four out of five CVD deaths are due to heart attacks and strokes, and one third of these death tend to occur prematurely in people under the age of 70 years. An estimated 17.9 million deaths had taken place from cardiovascular disorder in the year 2019, accounting for 32% of all the global deaths. Of these deaths, 85% death were due to stroke and heart attack. Due to the rise in the number of deaths because of stroke and heart attack, there is definitely a demand for better treatments and coronary angiography procedures that can in turn lead to prolonged life in patients, hence the market for Global Coronary Angiography Devices is certainly expected to rise.
According to the Center for Disease Control and Prevention, heart disease is the leading cause of death for men, women and people of most racial groups and ethnic groups in United States. As per the above mentioned source, it is observed in United States that one death tends to occur in every 36 seconds. Also, in the year 2017, the number of deaths that took place due to coronary artery disease were 365, 914.
According to the American Heart Association, 2021 Heart Disease and Stroke Statistics Updated Fact Sheet, in 2018, Coronary Heart Disease (CHD) was the leading cause (42.1%) of deaths attributable to CVD in the US, followed by stroke (17.0%), high blood pressure (11.0%), heart failure (9.6%), diseases of the arteries (2.9%), and other CVD (17.4%). In the year 2019, deaths that occurred due to CVD were approximately 18.6 million. Due to the increasing prevalence of cardiovascular disorders such as heart attack, coronary artery disease and stroke, there will be a boost observed in the coronary angiography procedures and increase in product approvals for advanced angiography techniques, in turn driving the market of coronary angiography devices.
According to a research paper titled “Cardiac Catheterization Risks and Complications” by Manda et al. in the year 2021, the number of cardiac catheterization procedures performed annually in United States are 1,000,000. Coronary angiography devices are also used extensively in minimally invasive surgeries. The above mentioned reasons will require the use of coronary angiography devices, hence leading to a boost in the global coronary angiography devices market.
However, the high cost of coronary angiography and the poor reimbursement policies in developing nations are expected to limit the market growth over the forecast period.
Coronary angiography devices market by Product (Angiography Systems, Angiography Catheters, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guide wires and Others), Coronary angiography devices market by Technology (X-Ray Angiography, CT Angiography, MR Angiography and Others), By Application (Diagnostics and Therapeutics), Coronary angiography devices market by End User (Hospitals, Diagnostic Centers and Others), and Coronary angiography devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the coronary angiography devices market product segment, the angiography systems segment is expected to be the largest growing segment during the forecast period. The Angiographic systems manufacturers have developed various new technologies to address the emerging cath labs trends comprising the need to reduce the radiation dosage, providing improved image quality and enabling advanced procedural image guidance. The newer imaging systems allows advanced 3-D imaging with rotational angiography, that uses a quick spin around the patient in order to create a computed tomography (CT)-like, 3-D image of the anatomy. Due to the increased visualization via these systems, there will be a huge demand for such devices in the market as they will be more preferred by the doctors, leading to a boost in the market demand for angiographic systems.
Technological advancements such as radiation reduction in angiography systems have increased their demand in the market. The ionizing radiations from medical imaging is often a point of concern for both the patients and operator, as the transcatheter procedures become more complex, longer imaging time and radiation exposure is a threat to the patients. However newer technologies have catered the reduction in radiation dosage. The newer, larger displays allow better visualization in cath labs enabling a better field of view, instead of the operators trying to visualize anatomic details on smaller screens. For instance, The Philips Azurion angiography system that tends to offer several imaging and software enhancements to aid guidance during complex interventional procedures. Thus, the technological advancements offered by these instruments will increase the demand of angiography systems in contrast to the other product types, leading to a rise in the angiography systems market.
Among all the regions, North America is expected to account for the largest share in the coronary angiography devices market. This domination is due to the improved reimbursement policies of coronary angiography procedures, and high adoption of technological advancements owing to the rise in healthcare expenditure by the US government. Also, the growing investments in the healthcare sector as well as the increasing acquisitions, mergers and collaborations has also result in driving the North America coronary angiography market.
The market for coronary angiography devices witnessed a period of stagnancy due to the outbreak of COVID-19. However, with the relaxation in lockdown guidelines, the normalcy is being restored in the medical and healthcare sector as well. The United States represents the largest market worldwide supported by developed healthcare infrastructure and strong adoption of advanced imaging technologies. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the market. For instance, on November 03, 2020, Food and Drug Administration has cleared the Boston Scientific Ranger Drug-coated Balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA). Due to the increase in product launches and FDA approvals across the North American region, there will be a surge observed in the coronary angiography devices market. Various other technological advancements such as improved image quality and lesser radiation exposure has also increased the adoption for coronary angiography devices in the market, thereby driving the coronary angiography market.
Some of the key market players operating in the Coronary Angiography Devices market includes Terumo Medical Corporation, Boston Scientific Corporation, Canon Medical Systems, Braun Melsungen AG, Angiodynamics, Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, Royal Philips Electronics, GE Healthcare, Medtronic, Inc., Shimadzu Corporation, Siemens Healthcare, Cordis (A Cardinal Health Company), Translumina, Merit Medical Systems and others.
What is Coronary Angiography Devices?
Coronary angiography is a minimally invasive procedure which utilizes a contrast material and X-rays in order to study and observe the blood flow via arteries in the heart. Various devices used in the procedure such as the Angiography Systems, Catheters, Guidewire, Balloons among others are known as the Coronary Angiography Devices.
What is the market for Global Coronary Angiography Devices?
Global Coronary Angiography Devices Market was valued at USD 11.72 billion in 2021, growing at a CAGR of 6.18% during the forecast period from 2022 to 2027, to reach USD 16.80 billion by 2027.
What are the drivers for Global Coronary Angiography Devices?
The major drivers driving the demand for Coronary Angiography Devices are the rising prevalence of cardiovascular disorders, increase in technological advancements, and increase in the number of coronary angiography procedures and the rise in product approval for advanced angiography techniques.
What are the key players operating in Global Coronary Angiography Devices?
Some of the key market players operating in the Diagnostic Imaging Equipment market includes Terumo Medical Corporation, Boston Scientific Corporation, Canon Medical Systems, Braun Melsungen AG, Angiodynamics, Abbott Vascular, and others.
What regions has the highest share in Coronary Angiography Devices market?
North America is expected to dominate the overall Coronary Angiography Devices market during the forecast period, 2022 to 2027. This domination is due to the rising number of conferences and foundations increasing awareness among people, the rise observed in healthcare investments, increase in mergers and acquisitions along with the introduction of various novel coronary angiography devices in the North American market.
This product will be updated with the latest data at the time of order. Consequently, dispatch time for this product will be 7-10 business days.
Global Coronary Angiography Devices Market was valued at USD 11.72 billion in 2021, growing at a CAGR of 6.18% during the forecast period from 2022 to 2027, to reach USD 16.80 billion by 2027. The demand for Coronary Angiography Devices is primarily witnessing growth on account of the growing prevalence of cardiovascular diseases, rising numbers of coronary angiography procedures, technological advancements in coronary angiography devices and increasing product approvals for advanced angiography techniques.
Coronary Angiography Devices Market Dynamics:
The rising prevalence of patients suffering from cardiovascular disease is one of the leading cause of death globally, taking an estimated 17.9 million lives every year. According to the World Health Organization (WHO), more than four out of five CVD deaths are due to heart attacks and strokes, and one third of these death tend to occur prematurely in people under the age of 70 years. An estimated 17.9 million deaths had taken place from cardiovascular disorder in the year 2019, accounting for 32% of all the global deaths. Of these deaths, 85% death were due to stroke and heart attack. Due to the rise in the number of deaths because of stroke and heart attack, there is definitely a demand for better treatments and coronary angiography procedures that can in turn lead to prolonged life in patients, hence the market for Global Coronary Angiography Devices is certainly expected to rise.
According to the Center for Disease Control and Prevention, heart disease is the leading cause of death for men, women and people of most racial groups and ethnic groups in United States. As per the above mentioned source, it is observed in United States that one death tends to occur in every 36 seconds. Also, in the year 2017, the number of deaths that took place due to coronary artery disease were 365, 914.
According to the American Heart Association, 2021 Heart Disease and Stroke Statistics Updated Fact Sheet, in 2018, Coronary Heart Disease (CHD) was the leading cause (42.1%) of deaths attributable to CVD in the US, followed by stroke (17.0%), high blood pressure (11.0%), heart failure (9.6%), diseases of the arteries (2.9%), and other CVD (17.4%). In the year 2019, deaths that occurred due to CVD were approximately 18.6 million. Due to the increasing prevalence of cardiovascular disorders such as heart attack, coronary artery disease and stroke, there will be a boost observed in the coronary angiography procedures and increase in product approvals for advanced angiography techniques, in turn driving the market of coronary angiography devices.
According to a research paper titled “Cardiac Catheterization Risks and Complications” by Manda et al. in the year 2021, the number of cardiac catheterization procedures performed annually in United States are 1,000,000. Coronary angiography devices are also used extensively in minimally invasive surgeries. The above mentioned reasons will require the use of coronary angiography devices, hence leading to a boost in the global coronary angiography devices market.
However, the high cost of coronary angiography and the poor reimbursement policies in developing nations are expected to limit the market growth over the forecast period.
Coronary Angiography Devices Market Segment Analysis:
Coronary angiography devices market by Product (Angiography Systems, Angiography Catheters, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guide wires and Others), Coronary angiography devices market by Technology (X-Ray Angiography, CT Angiography, MR Angiography and Others), By Application (Diagnostics and Therapeutics), Coronary angiography devices market by End User (Hospitals, Diagnostic Centers and Others), and Coronary angiography devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the coronary angiography devices market product segment, the angiography systems segment is expected to be the largest growing segment during the forecast period. The Angiographic systems manufacturers have developed various new technologies to address the emerging cath labs trends comprising the need to reduce the radiation dosage, providing improved image quality and enabling advanced procedural image guidance. The newer imaging systems allows advanced 3-D imaging with rotational angiography, that uses a quick spin around the patient in order to create a computed tomography (CT)-like, 3-D image of the anatomy. Due to the increased visualization via these systems, there will be a huge demand for such devices in the market as they will be more preferred by the doctors, leading to a boost in the market demand for angiographic systems.
Technological advancements such as radiation reduction in angiography systems have increased their demand in the market. The ionizing radiations from medical imaging is often a point of concern for both the patients and operator, as the transcatheter procedures become more complex, longer imaging time and radiation exposure is a threat to the patients. However newer technologies have catered the reduction in radiation dosage. The newer, larger displays allow better visualization in cath labs enabling a better field of view, instead of the operators trying to visualize anatomic details on smaller screens. For instance, The Philips Azurion angiography system that tends to offer several imaging and software enhancements to aid guidance during complex interventional procedures. Thus, the technological advancements offered by these instruments will increase the demand of angiography systems in contrast to the other product types, leading to a rise in the angiography systems market.
North America is expected to dominate the overall Coronary Angiography Devices Market:
Among all the regions, North America is expected to account for the largest share in the coronary angiography devices market. This domination is due to the improved reimbursement policies of coronary angiography procedures, and high adoption of technological advancements owing to the rise in healthcare expenditure by the US government. Also, the growing investments in the healthcare sector as well as the increasing acquisitions, mergers and collaborations has also result in driving the North America coronary angiography market.
The market for coronary angiography devices witnessed a period of stagnancy due to the outbreak of COVID-19. However, with the relaxation in lockdown guidelines, the normalcy is being restored in the medical and healthcare sector as well. The United States represents the largest market worldwide supported by developed healthcare infrastructure and strong adoption of advanced imaging technologies. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the market. For instance, on November 03, 2020, Food and Drug Administration has cleared the Boston Scientific Ranger Drug-coated Balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA). Due to the increase in product launches and FDA approvals across the North American region, there will be a surge observed in the coronary angiography devices market. Various other technological advancements such as improved image quality and lesser radiation exposure has also increased the adoption for coronary angiography devices in the market, thereby driving the coronary angiography market.
Coronary Angiography Devices Market Key Players:
Some of the key market players operating in the Coronary Angiography Devices market includes Terumo Medical Corporation, Boston Scientific Corporation, Canon Medical Systems, Braun Melsungen AG, Angiodynamics, Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, Royal Philips Electronics, GE Healthcare, Medtronic, Inc., Shimadzu Corporation, Siemens Healthcare, Cordis (A Cardinal Health Company), Translumina, Merit Medical Systems and others.
Recent Developmental Activities in Coronary Angiography Devices Market:
- On July 16, 2021, Canon Medical had partnered with Cleerly for tackling heart disease. The collaboration breaks new ground by integrating Canon's AI-powered CT technology with Cleerly's digital pathway solution for analysis of coronary artery disease.
- On December 01, 2020, GE Healthcare had introduced the Allia IGS 7 system. That uses AI-optimized dose and imaging settings and enables easier use of rotational angiography.
- On March 11, 2020, Kinepict Health had received FDA 510(k) clearance for its Kinepict Medical Imaging Tool (KMIT) software, which uses the Digital Variance Angiography (DVA).
- On February 11, 2020, Boston Scientific Corporation had recalled the Imager II Angiographic catheters due to tip detachment via a patient procedure or during the procedure preparation.
- Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the Global Coronary Angiography Devices Market.
- Various opportunities available for the other competitor in the Coronary Angiography Devices Market space.
- What are the top performing segments in 2021? How these segments will perform in 2027?
- Which is the top-performing regions and countries in the current market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for market growth in the coming future?
Target Audience who can be benefited from Coronary Angiography Devices Market Report Study
- Coronary Angiography Devices providers
- Research organizations and consulting companies
- Coronary Angiography Devices-related organization, association, forum, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders
- Various End-users who want to know more about the Coronary Angiography Devices Market and latest technological developments in the Coronary Angiography Devices market.
Frequently Asked Questions for Coronary Angiography Devices Market:
What is Coronary Angiography Devices?
Coronary angiography is a minimally invasive procedure which utilizes a contrast material and X-rays in order to study and observe the blood flow via arteries in the heart. Various devices used in the procedure such as the Angiography Systems, Catheters, Guidewire, Balloons among others are known as the Coronary Angiography Devices.
What is the market for Global Coronary Angiography Devices?
Global Coronary Angiography Devices Market was valued at USD 11.72 billion in 2021, growing at a CAGR of 6.18% during the forecast period from 2022 to 2027, to reach USD 16.80 billion by 2027.
What are the drivers for Global Coronary Angiography Devices?
The major drivers driving the demand for Coronary Angiography Devices are the rising prevalence of cardiovascular disorders, increase in technological advancements, and increase in the number of coronary angiography procedures and the rise in product approval for advanced angiography techniques.
What are the key players operating in Global Coronary Angiography Devices?
Some of the key market players operating in the Diagnostic Imaging Equipment market includes Terumo Medical Corporation, Boston Scientific Corporation, Canon Medical Systems, Braun Melsungen AG, Angiodynamics, Abbott Vascular, and others.
What regions has the highest share in Coronary Angiography Devices market?
North America is expected to dominate the overall Coronary Angiography Devices market during the forecast period, 2022 to 2027. This domination is due to the rising number of conferences and foundations increasing awareness among people, the rise observed in healthcare investments, increase in mergers and acquisitions along with the introduction of various novel coronary angiography devices in the North American market.
This product will be updated with the latest data at the time of order. Consequently, dispatch time for this product will be 7-10 business days.
Table of Contents
1. Coronary Angiography Devices Report Introduction2. Coronary Angiography Devices Executive summary
2.1 Scope of the Study
2.2 Market at Glance
2.3 Competitive Assessment
2.4 Financial Benchmarking
3. Regulatory and Patent Analysis
3.1 The United States
3.2 Europe
3.2.1 Germany
3.2.2 France
3.2.3 Italy
3.2.4 Spain
3.2.5 U.K.
3.3 Japan
4. Coronary Angiography Devices Key Factors Analysis
4.1 Coronary Angiography Devices Market Drivers
4.1.1 Growing prevalence of cardiovascular
4.1.2 Rising numbers of coronary angiography procedures
4.1.3 Technological advancements in coronary angiography devices
4.1.4 Increasing product approvals for advanced angiography techniques
4.2 Coronary Angiography Devices Market Restraints and Challenges
4.2.1 High cost of Coronary Angiography Devices
4.2.2 Poor Reimbursement Policies
4.3 Coronary Angiography Devices Market Opportunities
4.3.1 Increasing focus towards cardiovascular diseases in low- and middle-income countries
5. Coronary Angiography Devices Porter's Five Forces Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Consumers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry
6. COVID-19 Impact Analysis on Coronary Angiography Devices Market
7. Coronary Angiography Devices Market Layout
7.1 By Product
7.1.1 Angiography Systems
7.1.2 Angiography Catheters
7.1.3 Vascular Closure Devices (VCDs)
7.1.4 Angiography Balloons
7.1.5 Angiography Guidewires
7.1.6 Others
7.2 By Technology
7.2.1 X-Ray Angiography
7.2.2 CT Angiography
7.2.3 MR Angiography
7.2.4 Other
7.3 By Application
7.3.1 Diagnostics
7.3.2 Therapeutics
7.4 By End User
7.4.1 Hospitals
7.4.2 Diagnostic Centers
7.4.3 Others
7.5 By Geography
7.5.1 North America
7.5.1.1 North America Coronary Angiography Devices Market, by Product
7.5.1.2 North America Coronary Angiography Devices Market, by Technology
7.5.1.3 North America Coronary Angiography Devices Market, by Application
7.5.1.4 North America Coronary Angiography Devices Market, by End User
7.5.1.5 North America Coronary Angiography Devices Market, by Country
7.5.1.5.1 United States
7.5.1.5.2 Canada
7.5.1.5.3 Mexico
7.5.2 Europe
7.5.2.1 Europe Coronary Angiography Devices Market, by Product
7.5.2.2 Europe Coronary Angiography Devices Market, by End User
7.5.2.3 Europe Coronary Angiography Devices Market, Technology
7.5.2.4 Europe Coronary Angiography Devices Market, by Application
7.5.2.5 Europe Coronary Angiography Devices Market, by Country
7.5.2.5.1 France
7.5.2.5.2 Germany
7.5.2.5.3 United Kingdom
7.5.2.5.4 Italy
7.5.2.5.5 Spain
7.5.2.5.6 Russia
7.5.2.5.7 Rest of Europe
7.5.3 Asia-Pacific
7.5.3.1 Asia-Pacific Coronary Angiography Devices Market, by Product
7.5.3.2 Asia-Pacific Coronary Angiography Devices Market, by End User
7.5.3.3 Asia-Pacific Coronary Angiography Devices Market, by Technology
7.5.3.4 Asia-Pacific Coronary Angiography Devices Market, by Application
7.5.3.5 Asia-Pacific Coronary Angiography Devices Market, by Country
7.5.3.5.1 China
7.5.3.5.2 Japan
7.5.3.5.3 India
7.5.3.5.4 Australia
7.5.3.5.5 South Korea
7.5.3.5.6 Rest of Asia Pacific
7.5.4 Rest of the World (RoW)
7.5.4.1 RoW Coronary Angiography Devices Market, by Product
7.5.4.2 RoW Coronary Angiography Devices Market, by End User
7.5.4.3 RoW Coronary Angiography Devices Market, by Technology
7.5.4.4 RoW Coronary Angiography Devices Market, by Application
7.5.4.5 RoW Coronary Angiography Devices Market, by Region
7.5.5.3.1 Middle East
7.5.5.3.2 Africa
7.5.5.3.3 South America
8. Coronary Angiography Devices Global Company Share Analysis - Key 3-5 Companies
9. Coronary Angiography Devices Company and Product Profiles
9.1 Terumo Medical Corporation
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4 Product Listing
9.1.5. Entropy
9.2 Boston Scientific Corporation
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Financial Overview
9.2.4 Product Listing
9.2.5. Entropy
9.3 Canon Medical Systems
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Financial Overview
9.3.4 Product Listing
9.3.5. Entropy
9.4 Braun Melsungen AG
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Financial Overview
9.4.4 Product Listing
9.4.5. Entropy
9.5 Angiodynamics
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Financial Overview
9.5.4 Product Listing
9.5.5. Entropy
9.6 Abbott Vascular (Abbott Laboratories
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Financial Overview
9.6.4 Product Listing
9.6.5. Entropy
9.7 Toshiba Medical Systems Corporation
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Financial Overview
9.7.4 Product Listing
9.7.5. Entropy
9.8 Royal Philips Electronics
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Financial Overview
9.8.4 Product Listing
9.8.5. Entropy
9.9 GE Healthcare
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Financial Overview
9.9.4 Product Listing
9.9.5. Entropy
9.10 Medtronic, Inc.
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Financial Overview
9.10.4 Product Listing
9.10.5. Entropy
9.11 Shimadzu Corporation
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Financial Overview
9.11.4 Product Listing
9.11.5. Entropy
9.12 Siemens Healthcare
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Financial Overview
9.12.4 Product Listing
9.12.5. Entropy
9.13 Cordis (A Cardinal Health Company)
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Financial Overview
9.13.4 Product Listing
9.13.5. Entropy
9.14 Translumina
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Financial Overview
9.14.4 Product Listing
9.14.5. Entropy
9.15 Merit Medical Systems
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Financial Overview
9.15.4 Product Listing
9.15.5. Entropy
10. PROJECT APPROACH
10.1 Secondary Sources
10.2 Primary Sources
10.3 Data Triangulation
10.4 Key Expert Opinions
11. KOL Views
12. Publisher Capabilities
13. Disclaimer
14. About the PublisherList of Tables
Table 1 Competitive Analysis
Table 2 COVID-19 Impact Analysis
Table 3 Coronary Angiography Devices in Global (2019-2027)
Table 4 Coronary Angiography Devices in Global by Product (2019-2027)
Table 5 Coronary Angiography Devices in Global by Technology (2019-2027)
Table 6 Coronary Angiography Devices in Global by Application (2019-2027)
Table 7 Coronary Angiography Devices in Global by End User (2019-2027)
Table 8 Coronary Angiography Devices in Global by Geography (2019-2027)
Table 9 Coronary Angiography Devices in North America (2019-2027)
Table 10 Coronary Angiography Devices in North America by Product (2019-2027)
Table 11 Coronary Angiography Devices in North America by Technology (2019-2027)
Table 12 Coronary Angiography Devices in North America by Application (2019-2027)
Table 13 Coronary Angiography Devices in North America by End User (2019-2027)
Table 14 Coronary Angiography Devices in North America by Country (2019-2027)
Table 15 Coronary Angiography Devices in the US (2019-2027)
Table 16 Coronary Angiography Devices in Canada (2019-2027)
Table 17 Coronary Angiography Devices in Mexico (2019-2027)
Table 18 Coronary Angiography Devices in Europe (2019-2027)
Table 19 Coronary Angiography Devices in Europe by Product (2019-2027)
Table 20 Coronary Angiography Devices in Europe by Technology (2019-2027)
Table 21 Coronary Angiography Devices in Europe by Application (2019-2027)
Table 22 Coronary Angiography Devices in Europe by End User (2019-2027)
Table 23 Coronary Angiography Devices in Europe by Country (2019-2027)
Table 24 Coronary Angiography Devices in France (2019-2027)
Table 25 Coronary Angiography Devices in Germany (2019-2027)
Table 26 Coronary Angiography Devices in UK (2019-2027)
Table 27 Coronary Angiography Devices in Italy (2019-2027)
Table 28 Coronary Angiography Devices in Spain (2019-2027)
Table 29 Coronary Angiography Devices in Russia (2019-2027)
Table 30 Coronary Angiography Devices in Rest of Europe (2019-2027)
Table 31 Coronary Angiography Devices in Asia Pacific (2019-2027)
Table 32 Coronary Angiography Devices in Asia Pacific by Product (2019-2027)
Table 33 Coronary Angiography Devices in Asia Pacific by Technology (2019-2027)
Table 34 Coronary Angiography Devices in Asia Pacific by Application (2019-2027)
Table 35 Coronary Angiography Devices in Asia Pacific by End User (2019-2027)
Table 36 Coronary Angiography Devices in Asia Pacific by Country (2019-2027)
Table 37 Coronary Angiography Devices in China (2019-2027)
Table 38 Coronary Angiography Devices in Japan (2019-2027)
Table 39 Coronary Angiography Devices in India (2019-2027)
Table 40 Coronary Angiography Devices in Australia (2019-2027)
Table 41 Coronary Angiography Devices in South Korea (2019-2027)
Table 42 Coronary Angiography Devices in Rest of Asia Pacific (2019-2027)
Table 43 Coronary Angiography Devices in Rest of the World (2019-2027)
Table 44 Coronary Angiography Devices in Rest of the World by Product (2019-2027)
Table 45 Coronary Angiography Devices in Rest of the World by Technology (2019-2027)
Table 46 Coronary Angiography Devices in Rest of the World by Application (2019-2027)
Table 47 Coronary Angiography Devices in Rest of the World by End User (2019-2027)
Table 48 Coronary Angiography Devices in Rest of the World by Country (2019-2027)
Table 49 Coronary Angiography Devices in Middle East (2019-2027)
Table 50 Coronary Angiography Devices in Africa (2019-2027)
Table 51 Coronary Angiography Devices in South America (2019-2027)List of Figures
Figure 1 Competitive Analysis
Figure 2 COVID-19 Impact Analysis
Figure 3 Coronary Angiography Devices in Global (2019-2027)
Figure 4 Coronary Angiography Devices in Global by Product (2019-2027)
Figure 5 Coronary Angiography Devices in Global by Technology (2019-2027)
Figure 6 Coronary Angiography Devices in Global by Application (2019-2027)
Figure 7 Coronary Angiography Devices in Global by End User (2019-2027)
Figure 8 Coronary Angiography Devices in Global by Geography (2019-2027)
Figure 9 Coronary Angiography Devices in North America (2019-2027)
Figure 10 Coronary Angiography Devices in North America by Product (2019-2027)
Figure 11 Coronary Angiography Devices in North America by Technology (2019-2027)
Figure 12 Coronary Angiography Devices in North America by Application (2019-2027)
Figure 13 Coronary Angiography Devices in North America by End User (2019-2027)
Figure 14 Coronary Angiography Devices in North America by Country (2019-2027)
Figure 15 Coronary Angiography Devices in the US (2019-2027)
Figure 16 Coronary Angiography Devices in Canada (2019-2027)
Figure 17 Coronary Angiography Devices in Mexico (2019-2027)
Figure 18 Coronary Angiography Devices in Europe (2019-2027)
Figure 19 Coronary Angiography Devices in Europe by Product (2019-2027)
Figure 20 Coronary Angiography Devices in Europe by Technology (2019-2027)
Figure 21 Coronary Angiography Devices in Europe by Application (2019-2027)
Figure 22 Coronary Angiography Devices in Europe by End User (2019-2027)
Figure 23 Coronary Angiography Devices in Europe by Country (2019-2027)
Figure 24 Coronary Angiography Devices in France (2019-2027)
Figure 25 Coronary Angiography Devices in Germany (2019-2027)
Figure 26 Coronary Angiography Devices in UK (2019-2027)
Figure 27 Coronary Angiography Devices in Italy (2019-2027)
Figure 28 Coronary Angiography Devices in Spain (2019-2027)
Figure 29 Coronary Angiography Devices in Russia (2019-2027)
Figure 30 Coronary Angiography Devices in Rest of Europe (2019-2027)
Figure 31 Coronary Angiography Devices in Asia Pacific (2019-2027)
Figure 32 Coronary Angiography Devices in Asia Pacific by Product (2019-2027)
Figure 33 Coronary Angiography Devices in Asia Pacific by Technology (2019-2027)
Figure 34 Coronary Angiography Devices in Asia Pacific by Application (2019-2027)
Figure 35 Coronary Angiography Devices in Asia Pacific by End User (2019-2027)
Figure 36 Coronary Angiography Devices in Asia Pacific by Country (2019-2027)
Figure 37 Coronary Angiography Devices in China (2019-2027)
Figure 38 Coronary Angiography Devices in Japan (2019-2027)
Figure 39 Coronary Angiography Devices in India (2019-2027)
Figure 40 Coronary Angiography Devices in Australia (2019-2027)
Figure 41 Coronary Angiography Devices in South Korea (2019-2027)
Figure 42 Coronary Angiography Devices in Rest of Asia Pacific (2019-2027)
Figure 43 Coronary Angiography Devices in Rest of the World (2019-2027)
Figure 44 Coronary Angiography Devices in Rest of the World by Product (2019-2027)
Figure 45 Coronary Angiography Devices in Rest of the World by Technology (2019-2027)
Figure 46 Coronary Angiography Devices in Rest of the World by Application (2019-2027)
Figure 47 Coronary Angiography Devices in Rest of the World by End User (2019-2027)
Figure 48 Coronary Angiography Devices in Rest of the World by Country (2019-2027)
Figure 49 Coronary Angiography Devices in Middle East (2019-2027)
Figure 50 Coronary Angiography Devices in Africa (2019-2027)
Figure 51 Coronary Angiography Devices in South America (2019-2027)
Figure 52 Market Drivers
Figure 53 Market Barriers
Figure 54 Market Opportunities
Figure 55 PORTER'S Five Force Analysis
